Immunomedics Veltuzumab showed efficacy in ITP
Linkedin

Immunomedics Veltuzumab showed efficacy in ITP

London : United Kingdom | Dec 12, 2011 at 11:30 PM PST
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
P Immunomedics, known for development of monoclonal antibody-based products, has reported efficacy of subcutaneous injections of low-dose Veltuzumab in producing high rates of response in relapsed immune thrombocytopenia (ITP). Veltuzumab, a humanized anti-CD20 antibody was constructed... FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.